Longevity
-
Insilico Medicine Launches Longevity Vaccines Research Initiative Targeting Aging Diseases
HONG KONG, September 15 — Insilico Medicine is taking its AI drug-discovery engine into preventive medicine. The Hong Kong-listed company (HKEX: 3696)…
-
Metformin TAME Trial Tests Diabetes Drug for Anti-Aging Effects
NEW YORK, July 14 — A decades-old diabetes drug is now at the center of one of the most strategically significant aging…
-
Longevity Research Reveals Real Human Lifespan Extension Facts
WASHINGTON, July 14 — The global race to slow human aging is no longer a fringe scientific pursuit; it is a strategic…
-
Geneticist Nir Barzilai Leads TAME Trial Testing Metformin for Longevity
NEW YORK, July 14 — The figure that matters: 200. That is the number of peer-reviewed papers Dr. Nir Barzilai has published…
-
Nine Hallmarks of Aging: Cellular Drivers of Age Decline
WASHINGTON, July 14 — A scientific framework first laid out in 2013 has become the dominant map for researchers trying to understand…
-
Revolutionary Trial Aims to Treat Aging as a Medical Condition
NEW YORK, July 10 — Dr. Nir Barzilai, an Israeli-American geneticist, has spent decades researching aging as a target in biomedical research.…
-
Dr. Barzilai Targets Aging as Key to Combating Multiple Diseases
NEW YORK, July 10 — Dr. Nir Barzilai, an Israeli-American geneticist, has spent decades researching aging as a target in biomedical research.…
-
Aubrey de Grey: Radical Life Extension via Damage Repair
LONDON, July 10 — Aubrey de Grey, the British biomedical gerontologist whose radical vision of defeating aging has made him a polarizing…
-
Harvard’s Sinclair Tests Resveratrol, NAD+ in Aging Study
BOSTON, July 10 — The longevity research community is confronting a widening credibility gap, and Dr. David Sinclair, the Harvard Medical School…
-
Nir Barzilai Leads TAME Trial to Test Metformin for Aging
NEW YORK, July 8 — The biology of extreme old age has a meticulous chronicler in Nir Barzilai, the Israeli-American geneticist who…
-
Epigenetic Clocks: Measuring Biological Age and Predicting Mortality
LONDON, July 8 — The biological clock may be more than a metaphor. For over a decade, researchers have been building tools…
-
Metformin and Rapamycin: Drug Repurposing for Anti-Aging Effects
NEW YORK, July 8 — The calculus around aging research is shifting. Two drugs, one a decades-old diabetes staple and the other…
-
Caloric Restriction, Fasting Show Promise in Animal Studies
WASHINGTON, July 8 — For nearly a century, scientists have been chasing a tantalizing question: can eating less help us live longer?…
-
Longevity Market Reaches $25 Billion As Baby Boomers Age
NEW YORK, July 8 — $25 billion. That’s the figure that matters for anyone tracking the business of living longer. By the…
-
Optimal strength training window linked to lower mortality rates
BOSTON, July 3 — A Harvard T.H. Chan School of Public Health study tracking 147,000 adults over 30 years has identified a…
-
WILDLIFE HABITATS NEAR PARKS LINKED TO LONGER LIVES
WASHINGTON, June 30 — A new study has quantified something many visitors already sensed: America’s national parks are good for you. The…
-
New Study Reveals Long, Silent Buildup of Brain Changes Before Dementia Onset
The clock on dementia starts ticking long before the first forgotten name. New research confirms what many in the longevity field have…
-
First human trial of reverse-aging drug begins
BOSTON, June 11 — Life Biosciences, a Boston-based longevity company, has started the first FDA-approved human clinical trial to turn back time…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds


















